IFP Advisors’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-87
| Closed | -$271 | – | 3627 |
|
|
2023
Q1 | $271 | Sell |
87
-500
| -85% | -$1.56K | ﹤0.01% | 3249 |
|
|
2022
Q4 | $3K | Buy |
587
+87
| +17% | +$445 | ﹤0.01% | 4093 |
|
|
2022
Q3 | $2K | Hold |
500
| – | – | ﹤0.01% | 4473 |
|
|
2022
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 4252 |
|
|
2022
Q1 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 4252 |
|
|
2021
Q3 | – | Sell |
-150
| Closed | -$1K | – | 4910 |
|
|
2021
Q2 | $1K | Hold |
150
| – | – | ﹤0.01% | 2949 |
|
|
2021
Q1 | $1K | Hold |
150
| – | – | ﹤0.01% | 2881 |
|
|
2020
Q4 | $1K | Hold |
150
| – | – | ﹤0.01% | 2825 |
|
|
2020
Q3 | $0 | Hold |
150
| – | – | ﹤0.01% | 4181 |
|
|
2020
Q2 | $0 | Hold |
150
| – | – | ﹤0.01% | 3973 |
|
|
2020
Q1 | $0 | Hold |
150
| – | – | ﹤0.01% | 3858 |
|
|
2019
Q4 | $0 | Sell |
150
-500
| -77% | – | ﹤0.01% | 3795 |
|
|
2019
Q3 | $0 | Buy |
+650
| New | – | ﹤0.01% | 3777 |
|
|
2019
Q1 | – | Sell |
-150
| Closed | – | – | 3608 |
|
|
2018
Q4 | $0 | Hold |
150
| – | – | ﹤0.01% | 3910 |
|
|
2018
Q3 | $0 | Hold |
150
| – | – | ﹤0.01% | 4016 |
|
|
2018
Q2 | $0 | Hold |
150
| – | – | ﹤0.01% | 4081 |
|
|
2018
Q1 | $1K | Hold |
150
| – | – | ﹤0.01% | 3697 |
|
|
2017
Q4 | $1K | Sell |
150
-500
| -77% | -$3.33K | ﹤0.01% | 3697 |
|
|
2017
Q3 | $2K | Sell |
650
-125
| -16% | -$385 | ﹤0.01% | 3780 |
|
|
2017
Q2 | $2K | Hold |
775
| – | – | ﹤0.01% | 3758 |
|
|
2017
Q1 | $1K | Hold |
775
| – | – | ﹤0.01% | 3854 |
|
|
2016
Q4 | $1K | Hold |
775
| – | – | ﹤0.01% | 3851 |
|
|
2016
Q3 | $1K | Hold |
775
| – | – | ﹤0.01% | 3787 |
|
|
2016
Q2 | $2K | Buy |
+775
| New | +$2K | ﹤0.01% | 3508 |
|
|
2016
Q1 | – | Sell |
-775
| Closed | -$3K | – | 3641 |
|
|
2015
Q4 | $3K | Buy |
+775
| New | +$3K | ﹤0.01% | 3227 |
|